17
FDA’s Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs Erika Huffman, M.S., RAC Medical Research Manager NAMSA

New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

  • Upload
    namsa

  • View
    123

  • Download
    0

Embed Size (px)

DESCRIPTION

This presentation covers what the Acceptance Review is along with some of the frequently missed criteria for 510(k)s and PMAs.

Citation preview

Page 1: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

FDA’s Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

Erika Huffman, M.S., RAC

Medical Research Manager

NAMSA

Page 2: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

2

Overview What is the Acceptance Review? Most Frequently Missed Criteria (510k) Commonly Missed Criteria (PMA) What Happens Next?

Page 3: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

3

What is the Acceptance Review?

Page 4: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

4

The Acceptance Review is a “pre-review” step in FDA premarket review process

Traditional, Special, Abbreviated 510ks Refuse to Accept Policy

Original PMAs, Panel-track PMA Supplements Acceptance Review

Page 5: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

5

The Acceptance Review is also a quality control process for submissions

Limited to “general completeness” of submission Checklist of required information

Page 6: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

6

After a submission is accepted by the FDA’s Document Control Center (DCC), the Acceptance Review will occur within the first 15 calendar days of FDA review cycle

Page 7: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

7

Most Frequently Missed Criteria (510k)

Page 8: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

8

Shelf Life Proposed shelf life/expiration date explicitly stated Summary methods used to establish that device

performance is not adversely affected by aging Or, rationale for why the storage conditions are not

expected to affect device safety or effectiveness

Page 9: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

9

Biocompatibility Patient-contacting device components and

materials identified Biocompatibility assessment of patient-contacting

components provided

Page 10: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

10

Administrative 510(k) Summary or Statement provided Prior submissions (for same device) identified Indications for Use Complete Standards Data Report (FDA Form

3654) for each standard referenced submission Engineering drawings, figures, schematics

provided 510k number provided for each

component/accessory with prior clearance

Page 11: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

11

Commonly Missed Criteria (PMA)

Page 12: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

12

Manufacturing

Device Manufacturing information provided

Page 13: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

13

Supporting Data Full test reports provided Final versions of clinical protocols provided Results of all statistical analyses identified in the

protocol(s) included

Page 14: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

14

Administrative

All required FDA forms included

Page 15: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

15

What Happens Next?

Page 16: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

16

Accepted Notification of successful

acceptance review FDA review clock started FDA may request information

required as part of acceptance review during subsequent review process

Rejected Notification of unsuccessful

acceptance review Submit additional information

under originally issued submission number

Repeat Acceptance Review process

Page 17: New FDA Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs

17

To view the complete series about FDA’s Refuse to Accept Policy for 510(k)s and Acceptance Review Process for PMAs which will cover the background, process and timing, best practices and much more Visit NAMSA Seminars

For information about the regulatory services NAMSA offers Check out our Regulatory Consulting page

For additional information on this topic View our White Paper titled

The FDA Refuse to Accept Policy/Acceptance Review Process

Read our latest blog on The FDA Acceptance Review and Refuse to Accept Processes for PMAs and 510(k)s

If you have any questions or would like to request a quote Contact us at [email protected].